Alector, Inc. (ALEC) vs AN2 Therapeutics, Inc. (ANTX)

A side-by-side comparison of Alector, Inc. and AN2 Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ALEC

Alector, Inc.

$198M

$1.78HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT

ANTX

AN2 Therapeutics, Inc.

$185M

$5.14HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT

Total return — ALEC vs ANTX

growth of $100 · dividends reinvested · last 5y

ALEC -86.9% (-33.4%/yr)ANTX -63.6% (-18.3%/yr)ANTX compounded faster over this window

ALEC ANTX

ALEC vs ANTX: by the numbers

•ALEC is the larger company ($198M vs $185M market cap).
•Both run net losses; ANTX's is the smaller (0.00% vs -850.13% net margin).

Metrics side by side

Valuation

Metric	ALEC	ANTX
P/S ratio	14.25	N/A
P/B ratio	N/A	2.44

Profitability

Metric	ALEC	ANTX
Gross margin	54.09%	0.00%
Operating margin	-692.83%	0.00%
Net margin	-850.13%	0.00%
ROE	N/A	-47.78%
ROIC	-71.04%	-51.01%

Growth (annualized)

Metric	ALEC	ANTX
Revenue CAGR (5Y)	-8.35%	N/A
Total return CAGR (5Y)	-39.17%	N/A

Go deeper

Full ALEC analysis Full ANTX analysis Interactive comparison tool

Dig into the metrics

Alector ROE AN2 Therapeutics ROE Alector operating margin AN2 Therapeutics operating margin Alector revenue growth AN2 Therapeutics revenue growth Alector free cash flow AN2 Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.